Scholarly Index
J. Alfred Witjes
Radboud University Nijmegen; 42,945 total citations; 510 total publications; best world rank #6
Radboud University Nijmegen
42,945Total citations
510Total publications
100H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Bladder and Urothelial Cancer Treatments | Lifetime | 10 | NL 1 | 99.86 |
| Urinary and Genital Oncology Studies | Lifetime | 6 | NL 1 | 99.89 |
| Urological Disorders and Treatments | Lifetime | 17 | NL 1 | 99.79 |
| Urinary Tract Infections Management | Lifetime | 73 | NL 1 | 99.29 |
| Prostate Cancer Diagnosis and Treatment | Lifetime | 204 | NL 10 | 99.31 |
| Infectious Disease Case Reports and Treatments | Lifetime | 12 | NL 1 | 98.74 |
| Prostate Cancer Treatment and Research | Lifetime | 380 | NL 14 | 98.88 |
| Esophageal Cancer Research and Treatment | Lifetime | 295 | NL 27 | 98.29 |
| Cancer Diagnosis and Treatment | Lifetime | 754 | NL 29 | 96.53 |
| Urinary Bladder and Prostate Research | Lifetime | 509 | NL 13 | 97.50 |
| Urologic and reproductive health conditions | Lifetime | 365 | NL 12 | 97.76 |
| Bladder and Urothelial Cancer Treatments | 2021-2025 | 26 | NL 2 | 99.52 |
| Urinary and Genital Oncology Studies | 2021-2025 | 20 | NL 2 | 99.47 |
| Urological Disorders and Treatments | 2021-2025 | 54 | NL 2 | 97.98 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 893 | NL 23 | 96.54 |